Find uplifting stories about heroes, innovations, and solutions
27 results for "cancer vaccine"
A groundbreaking mRNA therapy reduced melanoma recurrence or death by 49% over five years when combined with immunotherapy. The personalized vaccine teaches patients' immune systems to recognize and attack their specific cancer cells.
A personalized cancer vaccine combined with immunotherapy has kept nearly 70% of melanoma patients cancer-free five years after surgery. The breakthrough offers new hope for preventing one of the deadliest skin cancers from coming back.
Egypt and Russia are joining forces to develop breakthrough cancer treatments and share medical expertise. The partnership includes vaccine manufacturing collaboration and a new medical tourism initiative connecting patients with advanced care.
Egypt and Russia are joining forces to develop breakthrough cancer treatments and share medical expertise. The partnership could bring advanced cancer care to millions across both nations.
A personalized DNA vaccine for glioblastoma, one of the deadliest brain cancers, doubled survival rates in early trials and kept one patient cancer-free for nearly five years. The vaccine trains each patient's immune system to recognize up to 40 unique cancer proteins, making it harder for tumors to hide.
Scientists at MIT have developed a revolutionary cancer vaccine that completely eliminated tumors in most test mice by supercharging the body's T cells. The breakthrough could transform how we fight cancer and infectious diseases.
A personalized DNA vaccine for glioblastoma, one of the deadliest brain cancers, helped patients live twice as long as usual in a groundbreaking trial. One patient remains cancer-free nearly five years later.
A groundbreaking cancer vaccine has nearly eliminated cervical cancer in young women, with doctors reporting they rarely see the disease in patients under 25 anymore. The success story reveals how vaccines can prevent cancer and save lives.
A groundbreaking clinical trial at Stony Brook Medicine is testing a vaccine designed to prevent breast cancer from coming back and spreading throughout the body. Survivors like Christina Amitrano are volunteering to help make this breakthrough treatment available to future patients.
A new cancer vaccine showed promising safety and immune response in 36 patients with advanced lung, ovarian, and prostate cancer. The treatment caused only minor injection-site reactions while triggering strong immune responses.
After political backlash threatened to derail cancer research, mRNA vaccines are delivering real hope to patients with deadly diseases like pancreatic cancer. New funding and positive trial results suggest the technology could save thousands of lives.
A personalized mRNA vaccine is helping pancreatic cancer patients survive six years and counting, with nearly 90% of responders still alive. For a disease with just 13% five-year survival, this breakthrough offers real hope.
A personalized mRNA vaccine helped eight pancreatic cancer patients generate powerful immune responses, and seven of them are still alive six years later. The breakthrough offers new hope for one of the deadliest cancers, where fewer than 13% of patients survive five years.
A 60-year-old melanoma patient in Moscow just received Russia's first personalized mRNA cancer vaccine, designed specifically for their tumor. The breakthrough treatment trains the immune system to target cancer cells unique to each patient.
When his beloved dog faced terminal cancer with no options left, a machine learning expert turned to AI tools to design a personalized vaccine in months. Rosie's tumor shrunk 75%, and her story reveals what's possible when everyday people access powerful technology.
A groundbreaking breast cancer vaccine has received patent approval in South Korea, marking a major step toward preventing the world's most common cancer in women. The vaccine showed promising safety results and immune responses in 74% of trial participants.
Scientists at UCLA have achieved breakthrough results in treating advanced colorectal cancer, with a new combination therapy doubling two-year survival rates. The research team is also making major strides in prevention, from mailing free screening kits to developing powerful cancer vaccines.
A personalized mRNA vaccine helped 11 women with aggressive breast cancer stay cancer-free for up to six years. The groundbreaking treatment trained their immune systems to recognize and fight cancer cells using their own tumor's genetic code.
Scientists have developed a therapeutic vaccine that successfully fought HPV-related cancers in mice, offering hope for patients with advanced disease. Unlike current vaccines that only prevent infection, this treatment targets existing tumors.
Scientists have designed a cancer vaccine that successfully fought HPV-related throat tumors in mice, offering hope for people battling these aggressive cancers. The breakthrough lies in how the vaccine's components are arranged, making it more effective at training the immune system to recognize and destroy cancer cells.
Showing 20 of 27